Essentia BioSciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.2M

  • Investors
  • 11

Essentia BioSciences General Information

Description

Provider of biotechnology services intended to support advanced cell and gene therapy development. The company offers specialized capabilities, including cell characterization, identity verification, genetic stability assessment, and contaminant detection across critical stages of biopharmaceutical research and manufacturing, enabling patients with effective pancreatic islet treatments.

Contact Information

Website
www.essentiabiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 301, Building 8, Comprehensive Bonded Zone, Daxing Airport Area
  • Free Trade Pilot Zone, Number 2, Jiyun Street, Lixian Town, Daxing District
  • Beijing, 102600
  • China
+86 152
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 301, Building 8, Comprehensive Bonded Zone, Daxing Airport Area
  • Free Trade Pilot Zone, Number 2, Jiyun Street, Lixian Town, Daxing District
  • Beijing, 102600
  • China
+86 152

Essentia BioSciences Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Essentia BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 01-Jan-2026 $14.2M Completed Generating Revenue
4. Early Stage VC 12-Sep-2024 Completed Generating Revenue
3. Early Stage VC 04-Feb-2024 Completed Generating Revenue
2. Early Stage VC 24-Oct-2023 $1.57M Completed Generating Revenue
1. Seed Round 30-Mar-2022 $1.57M $1.57M Completed Startup
To view Essentia BioSciences’s complete valuation and funding history, request access »

Essentia BioSciences Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Essentia BioSciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202500454-D0 Stem cell differentiation Pending 16-Dec-2024
GB-2704152-A Stem cell differentiation Pending 16-Dec-2024

Essentia BioSciences Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
AlphaMol Corporation Minority
Bluesky TRS VC-Backed Company Minority
Qingdao Haier Venture Capital Corporate Venture Capital Minority
Qingsong Fund Venture Capital Minority
Beijing Changhe Investment Management Growth/Expansion Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Essentia BioSciences FAQs

  • When was Essentia BioSciences founded?

    Essentia BioSciences was founded in 2021.

  • Where is Essentia BioSciences headquartered?

    Essentia BioSciences is headquartered in Beijing, China.

  • What industry is Essentia BioSciences in?

    Essentia BioSciences’s primary industry is Biotechnology.

  • Is Essentia BioSciences a private or public company?

    Essentia BioSciences is a Private company.

  • What is Essentia BioSciences’s current revenue?

    The current revenue for Essentia BioSciences is .

  • How much funding has Essentia BioSciences raised over time?

    Essentia BioSciences has raised $15.8M.

  • Who are Essentia BioSciences’s investors?

    AlphaMol, Bluesky TRS, Qingdao Haier Venture Capital, Qingsong Fund, and Beijing Changhe Investment Management are 5 of 11 investors who have invested in Essentia BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process